きたああああああああああああああああああああああああああああああああ

ニューロサイエンスきたああああああああああああああああああああああああああ

わしのPCにきたあああああああああああああああああああああああああああああ

COVID-19ブロック新薬きたあああああああああああああああああああああああああ

JAPANで承認済カモスタッドきたあああああああああああああああああああああああ

うわあああああああああああああああああああああああああああああああああああ

ばばばば　爆上げぎゃああああああああああああああああああああああああああ

喘息　カモスタッドうわああああああああああああああああああああああああああ

速報
Potential drug to block coronavirus identified
Neuroscience News

A clinically proven drug known to block an enzyme essential for the viral entry of Coronavirus into the lungs blocks the COVID 19 (SARS-CoV-2) infection. The drug, Camostat mesilate,
is a drug approved in Japan to treat pancreatic inflammation. Results suggest this drug may also protect against COVID 19. Researchers call for further clinical trials.